Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Thrombocytopenia 8Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Leukemia 4Purpura, Thrombocytopenic, Idiopathic 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Jacobs syndrome 2Sarcoma 1Primary Myelofibrosis 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Healthy Volunteers 1Healthy Adults 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1Anemia 1

Interventions

Cyclophosphamide 45Peripheral Blood Stem Cell Transplantation 44fludarabine phosphate 40Busulfan 32Tacrolimus 27Filgrastim 26Methotrexate 24Cytarabine 24Cyclosporine 23Antilymphocyte Serum 22Radiotherapy 20Mycophenolic Acid 19Whole-Body Irradiation 18Etoposide 18Imatinib Mesylate 17Methylprednisolone 15Melphalan 13Cord Blood Stem Cell Transplantation 10sargramostim 9Thiotepa 9fludarabine 8Psychiatric Rehabilitation 8Dasatinib 8Topotecan 7Therapeutics 7Prednisone 7Flow Cytometry 7Decitabine 7Carboplatin 7merphos 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Blast Crisis × eltrombopag × Clear all
NCT01428635 2023-09-26

Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy

M.D. Anderson Cancer Center

Phase 2/3 Completed
21 enrolled 10 charts
Classical hematologyMyeloidOther hematologic neoplasm

Blast Crisis, Thrombocytopenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡